Search Results - "Schmelz, Monika"

Refine Results
  1. 1

    The AIDS and Cancer Specimen Resource (ACSR): HIV malignancy specimens and data available at no cost by Silver, Sylvia, Schmelz, Monika

    Published in AIDS research and therapy (28-08-2023)
    “…Abstract The goal of the AIDS and Cancer Specimen Resource (ACSR) is to play a major role in the advancement of HIV/AIDS cancer-related research/treatment by…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pak2 regulates myeloid-derived suppressor cell development in mice by Zeng, Yi, Hahn, Seongmin, Stokes, Jessica, Hoffman, Emely A., Schmelz, Monika, Proytcheva, Maria, Chernoff, Jonathan, Katsanis, Emmanuel

    Published in Blood advances (10-10-2017)
    “…Myeloid-derived suppressor cells (MDSCs) are CD11b+Gr1+ cells that induce T-cell hyporesponsiveness, thus impairing antitumor immunity. We have previously…”
    Get full text
    Journal Article
  4. 4
  5. 5

    In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancer by Ayala, Gustavo E., Wheeler, Thomas M., Shine, H. David, Schmelz, Monika, Frolov, Ana, Chakraborty, Subhendu, Rowley, David

    Published in The Prostate (01-11-2001)
    “…Background Little is understood regarding mechanisms of perineural invasion in prostate cancer progression. We present a novel model system and data that…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prognostic Criteria for Squamous Cell Cancer of the Skin by Jensen, Vanessa, M.D, Prasad, Anil R., M.D, Smith, Aaron, M.D, Raju, Menaka, M.D, Wendel, Christopher S., M.S, Schmelz, Monika, Ph.D, Leyva, William, M.D, Warneke, James, M.D, Krouse, Robert S., M.D

    Published in The Journal of surgical research (01-03-2010)
    “…Background Non-well-differentiated cutaneous squamous cell carcinomas may display a more aggressive behavior. It is important to better define prognostic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Cellular Immune Suppressor Activity Resides in Lymphocyte Cell Clusters Adjacent to Granulomata in Human Coccidioidomycosis by Li, Lijin, Dial, Sharon M, Schmelz, Monika, Rennels, Margaret A, Ampel, Neil M

    Published in Infection and Immunity (01-07-2005)
    “…The in situ immunologic response in human coccidioidomycosis remains undefined. To explore this further, pulmonary necrotizing coccidioidal granulomata were…”
    Get full text
    Journal Article
  10. 10

    Biorepository best practices for research and clinical investigations by Sanderson-November, Micheline, Silver, Sylvia, Hooker, Vanessa, Schmelz, Monika

    Published in Contemporary clinical trials (01-05-2022)
    “…Translational research requires good quality specimens to ensure the integrity of research results. Clinical research must rely not only on quality specimens,…”
    Get full text
    Journal Article
  11. 11

    Drebrin is a widespread actin-associating protein enriched at junctional plaques, defining a specific microfilament anchorage system in polar epithelial cells by Peitsch, Wiebke K., Grund, Christine, Kuhn, Caecilia, Schnölzer, Martina, Spring, Herbert, Schmelz, Monika, Franke, Werner W.

    Published in European journal of cell biology (01-11-1999)
    “…Using immunoblotting, immunprecipitation with subsequent fragment mass spectrometry, and immunolocalization techniques, we have detected the actin-binding ca…”
    Get full text
    Journal Article
  12. 12

    Come in Out of the Cold: Alternatives to Freezing for Microbial Biorepositories by Isaacs, Erica, Schmelz, Monika

    Published in Clinical microbiology newsletter (15-02-2017)
    “…Abstract Biorepositories are “libraries” in which biospecimens, bacteria, or DNA and RNA extracts are stored for either clinical or research purposes. Such…”
    Get full text
    Journal Article
  13. 13

    Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression by Sarwar, Shoib, Tome, Margaret E, Billheimer, Dean, Spier, Catherine, Smith, Catharine L, Persky, Daniel, Schmelz, Monika

    Published in Histology and histopathology (01-03-2024)
    “…Since the approval of brentuximab vedotin (BV), assessment of CD30 status by immunohistochemistry gained increasing importance in the clinical management of…”
    Get full text
    Journal Article
  14. 14

    PEAZ-1: A new human prostate neoplastic epithelial cell line by Schmelz, Monika, Cress, Anne E., Barrera, Jean, McDaniel, Kathy M., Davis, Tracy L., Fuchs, Laura, Dalkin, Bruce L., Nagle, Raymond B.

    Published in The Prostate (01-07-2001)
    “…BACKGROUND The generation of prostatic cell lines provides in vitro models for experimental studies of the pathogenesis of prostate carcinoma. Therefore, we…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Different Phenotypes in Human Prostate Cancer: α6 or α3 Integrin in Cell-extracellular Adhesion Sites by Schmelz, Monika, Cress, Anne E., Scott, Katherine M., Burger, Friederike, Cui, Haiyan, Sallam, Karim, McDaniel, Kathy M., Dalkin, Bruce L., Nagle, Raymond B.

    Published in Neoplasia (New York, N.Y.) (2002)
    “…The distribution of α6/α3 integrin in adhesion complexes at the basal membrane in human normal and cancer prostate glands was analyzed in 135 biopsies from 61…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Differences of bcl-2 protein expression between Merkel cells and Merkel cell carcinomas by Moll, I, Gillardon, F, Waltering, S, Schmelz, M, Moll, R

    Published in Journal of cutaneous pathology (01-04-1996)
    “…The bcl-2 gene, originally identified in B-cell lymphomas, encodes for proteins which may assume oncogenic functions by blocking apoptosis. Bcl-2 proteins are…”
    Get more information
    Journal Article
  19. 19

    A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma by Puvvada, Soham D, Guillén-Rodríguez, José M, Rivera, Xavier I, Heard, Kara, Inclan, Lora, Schmelz, Monika, Schatz, Jonathan H, Persky, Daniel O

    Published in Oncology (01-12-2017)
    “…Aggressive lymphomas (aNHL) including diffuse large B-cell lymphoma (DLBCL) have poor outcomes in relapsed refractory patients. Prior studies have demonstrated…”
    Get more information
    Journal Article
  20. 20